论文部分内容阅读
应用放射免疫(RIA)测定肝病患者血清(α_1-微球蛋白(α_1-m)的浓度,了解肝病患者肾功能的损害情况,现报告如下。 材料和方法 一、对象:130例肝病患者为我院门诊及住院病人(男110例,女20例),包括慢性肝炎24例、肝硬化40例、肝癌56例。肝硬化、肝癌病人均经血清AFP测定、B超、CT所证定。40例正常对照(男30例,女10例),既往无肝病史,肝肾功能实验正常,乙肝表面抗原阴性。 二、方法:α_1-m放免试剂盒由天津九鼎医学生物有限公司提供,按说明书操作,测定仪器为北京核仪器厂生产的FT-630G微机多探头γ计数器,数据微机自动化处理。
The application of radioimmunoassay (RIA) in the determination of serum (α_1-microglobulin (α_1-m) in patients with liver disease, to understand the damage of renal function in patients with liver disease, are reported as follows.Material and methods A, object: 130 patients with liver disease for me Hospital outpatient and inpatient (110 males and 20 females), including 24 cases of chronic hepatitis, cirrhosis 40 cases, liver cancer 56. Liver cirrhosis, liver cancer patients were determined by serum AFP, B ultrasound, CT .40 Cases of normal control (30 males and 10 females), no past history of liver disease, normal liver and kidney function tests, hepatitis B surface antigen negative.Methods: α_1-m radioimmunoassay kit provided by Tianjin Jiuding Medical Biological Co., Ltd., according to the instructions Operation, measurement equipment for the Beijing Nuclear Instrument Factory FT-630G microcomputer multi-probe γ counter, the data microcomputer automation.